Market Tracker

04/17 6:05pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

5.30
Data as of Apr 17
 -0.08 / -1.49%
Today’s Change
4.60
Today|||52-Week Range
7.84
-5.86%
Year-to-Date

Today’s Trading

Previous close5.38
Today’s open5.35
Day’s range5.23 - 5.49
Volume1,386,067
Average volume (3 months)2,386,711
Market cap$617.9M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+131.17%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book13.89

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.99-5.01%
INSMInsmed Inc+0.88+7.02%
ENTAEnanta Pharmaceutica...+0.26+0.78%
NLNKNewLink Genetics Cor...-0.24-1.14%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts